Regulus Therapeutics Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	4,073	1,389	-	-	-
Enterprise Value	4,119	1,347	-	-	-
Last Close Price	14.28	4.82	-	-	-
PE Ratio	22.58	9.94	-	-	-
PS Ratio	5.13	2.40	-	-	-
PB Ratio	3.95	1.52	-	-	-
P/TBV Ratio	4.70	1.65	-	-	-
P/FCF Ratio	23.28	252.00	-	-	-
P/OCF Ratio	11.59	5.56	-	-	-
EV/Sales Ratio	5.19	2.33	-	-	-
EV/EBITDA Ratio	13.47	6.62	-	-	-
EV/EBIT Ratio	18.18	7.74	-	-	-
EV/FCF Ratio	23.54	244.33	-	-	-
Debt / Equity Ratio	0.20	0.17	0.15	0.25	0.40
Debt / EBITDA Ratio	0.68	0.75	0.35	0.59	-
Debt / FCF Ratio	1.19	28.88	1.19	-	-
Asset Turnover	0.61	0.64	0.94	1.04	-
Quick Ratio	2.65	2.16	2.73	2.88	2.30
Current Ratio	2.84	2.37	2.74	2.89	2.31
Return on Equity (ROE)	17.84%	20.85%	45.67%	30.64%	-
Return on Assets (ROA)	10.87%	11.95%	21.91%	17.44%	-
Return on Capital (ROIC)	12.24%	13.91%	26.01%	19.97%	-
Return on Capital Employed (ROCE)	20.50%	17.60%	39.70%	36.10%	42.90%
Earnings Yield	4.20%	10.07%	-	-	-
FCF Yield	4.29%	0.40%	-	-	-
Dividend Yield	0.70%	2.08%	-	-	-
Payout Ratio	17.48%	10.12%	-	-	-
Buyback Yield / Dilution	-2.79%	-37.32%	-	22.10%	-
Total Shareholder Return	-2.09%	-35.25%	-	22.10%	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.